Biolinerx Ltd ADR (BLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,588 | -2,026 | 210 | 1,187 | 5,127 |
| Depreciation Amortization | 88 | 523 | 460 | 341 | 165 |
| Accounts receivable | 46 | 2,430 | 2,476 | 2,398 | 1,007 |
| Other Working Capital | 513 | 1,259 | 1,180 | 1,357 | -513 |
| Other Operating Activity | -339 | -10,260 | -9,200 | -8,051 | -8,377 |
| Operating Cash Flow | $-2,280 | $-8,074 | $-4,874 | $-2,768 | $-2,591 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,709 | -8,518 | -8,208 | -11,892 | -8,177 |
| PPE Investments | -6 | -25 | N/A | 11 | N/A |
| Purchase Sale Intangibles | N/A | -2 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -2 | 0 | 0 | 0 |
| Investing Cash Flow | $2,703 | $-8,545 | $-8,208 | $-11,881 | $-8,177 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,120 | -4,498 | -3,359 | -2,240 | -1,120 |
| Common Stock Issued | N/A | 13,894 | 13,894 | 13,554 | 10,697 |
| Other Financing Activity | -60 | -512 | -399 | -262 | -127 |
| Financing Cash Flow | $-1,180 | $8,884 | $10,136 | $11,052 | $9,450 |
| Exchange Rate Effect | 11 | 549 | 424 | 350 | -82 |
| Beginning Cash Position | 3,250 | 10,436 | 10,436 | 10,436 | 10,436 |
| End Cash Position | 2,504 | 3,250 | 7,914 | 7,189 | 9,036 |
| Net Cash Flow | $-746 | $-7,186 | $-2,522 | $-3,247 | $-1,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,280 | -8,074 | -4,874 | -2,768 | -2,591 |
| Capital Expenditure | -6 | -25 | N/A | 11 | N/A |
| Free Cash Flow | -2,286 | -8,099 | -4,874 | -2,757 | -2,591 |